Access to antimalarial drugs in the Asia–Pacific region during health emergency: a multinational cross-sectional investigation between 2020 and 2022
Yinuo Sun, Yuxuan Cui, Yangmu Huang, Ming Xu · 2025
Read Access to antimalarial drugs in the Asia–Pacific region during health emergency: a multinational cross-sectional investigation between 2020 and 2022 by Yinuo Sun, Yuxuan Cui, Yangmu Huang, Ming Xu (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12703887.txt.
Description
Yinuo Sun and co-authors study how well people in the Asia-Pacific region could get malaria drugs during the COVID-19 emergency. Their 2025 study covers six countries, among them India, Thailand, and Viet Nam, from 2020 to 2022. Malaria control in the region had already stalled, and the crisis made drug access worse.
The team pulled sales data for 37 malaria drugs from a large drug database. India had 31 of the drugs on sale, while Bangladesh and Viet Nam had only six each. One drug family, based on quinine, led sales in all six lands. The authors weigh use per case and cost per case, then test which national traits and supplier traits track with better access.
Catalog record
| CREATOR | Yinuo Sun, Yuxuan Cui, Yangmu Huang, Ming Xu |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 26 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |